Metraipolis › archive › dc_cf50e40a39bd
Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines — Europe PMC PMID:41128166
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41128166
- DOI
- 10.1111/jvh.70098
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T21:19:01.173Z
- SHA-256 of the archived text
2489c51495988473910fdd0395cb69db535d34ba942e960f57d698dd2e76a927- Stable URL of this page
https://metraipolis.com/documento/dc_cf50e40a39bd
How to cite
Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines — Europe PMC PMID:41128166 — Europe PMC (en), https://europepmc.org/article/MED/41128166 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cf50e40a39bd (Metraipolis archive dc_cf50e40a39bd, sha256 2489c51495988473910fdd0395cb69db535d34ba942e960f57d698dd2e76a927)
BibTeX
@misc{dccf50e40a39bd,
title = {Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines — Europe PMC PMID:41128166},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41128166},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cf50e40a39bd; sha256 2489c51495988473910fdd0395cb69db535d34ba942e960f57d698dd2e76a927},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41128166. Agents can read the archived copy with the MCP tool read_document.